Celcuity (CELC) Competitors $12.68 -0.10 (-0.78%) (As of 09:52 AM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends CELC vs. XGN, ENZ, RNLX, OPGN, FTRE, TDOC, VRDN, AHCO, CDNA, and AVAHShould you be buying Celcuity stock or one of its competitors? The main competitors of Celcuity include Exagen (XGN), Enzo Biochem (ENZ), Renalytix (RNLX), OpGen (OPGN), Fortrea (FTRE), Teladoc Health (TDOC), Viridian Therapeutics (VRDN), AdaptHealth (AHCO), CareDx (CDNA), and Aveanna Healthcare (AVAH). These companies are all part of the "healthcare" industry. Celcuity vs. Exagen Enzo Biochem Renalytix OpGen Fortrea Teladoc Health Viridian Therapeutics AdaptHealth CareDx Aveanna Healthcare Celcuity (NASDAQ:CELC) and Exagen (NASDAQ:XGN) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, analyst recommendations, risk, valuation, institutional ownership, community ranking, earnings and media sentiment. Which has more risk and volatility, CELC or XGN? Celcuity has a beta of 0.76, meaning that its stock price is 24% less volatile than the S&P 500. Comparatively, Exagen has a beta of 1.35, meaning that its stock price is 35% more volatile than the S&P 500. Do institutionals & insiders have more ownership in CELC or XGN? 63.3% of Celcuity shares are owned by institutional investors. Comparatively, 75.3% of Exagen shares are owned by institutional investors. 15.8% of Celcuity shares are owned by insiders. Comparatively, 26.1% of Exagen shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Does the MarketBeat Community prefer CELC or XGN? Celcuity received 316 more outperform votes than Exagen when rated by MarketBeat users. Likewise, 67.54% of users gave Celcuity an outperform vote while only 55.26% of users gave Exagen an outperform vote. CompanyUnderperformOutperformCelcuityOutperform Votes33767.54% Underperform Votes16232.46% ExagenOutperform Votes2155.26% Underperform Votes1744.74% Does the media refer more to CELC or XGN? In the previous week, Exagen had 2 more articles in the media than Celcuity. MarketBeat recorded 15 mentions for Exagen and 13 mentions for Celcuity. Exagen's average media sentiment score of 0.84 beat Celcuity's score of 0.54 indicating that Exagen is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Celcuity 3 Very Positive mention(s) 4 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Exagen 3 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts recommend CELC or XGN? Celcuity presently has a consensus price target of $29.17, indicating a potential upside of 130.02%. Exagen has a consensus price target of $7.00, indicating a potential upside of 52.84%. Given Celcuity's stronger consensus rating and higher probable upside, analysts clearly believe Celcuity is more favorable than Exagen.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Celcuity 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 3.14Exagen 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is CELC or XGN more profitable? Celcuity has a net margin of 0.00% compared to Exagen's net margin of -30.36%. Celcuity's return on equity of -62.66% beat Exagen's return on equity.Company Net Margins Return on Equity Return on Assets CelcuityN/A -62.66% -39.78% Exagen -30.36%-92.58%-33.74% Which has higher earnings and valuation, CELC or XGN? Exagen has higher revenue and earnings than Celcuity. Exagen is trading at a lower price-to-earnings ratio than Celcuity, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCelcuityN/AN/A-$63.78M-$2.61-4.86Exagen$52.55M1.54-$23.69M-$0.94-4.87 SummaryCelcuity and Exagen tied by winning 9 of the 18 factors compared between the two stocks. Ad Crypto 101 MediaBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW Get Celcuity News Delivered to You Automatically Sign up to receive the latest news and ratings for CELC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CELC vs. The Competition Export to ExcelMetricCelcuityMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$470.81M$3.07B$5.07B$8.80BDividend YieldN/A11.18%4.99%4.07%P/E Ratio-4.869.0389.5613.60Price / SalesN/A215.431,224.8087.40Price / CashN/A406.7839.4536.27Price / Book3.153.206.976.33Net Income-$63.78M-$32.86M$119.04M$225.93M7 Day Performance-10.13%0.59%-1.78%-0.96%1 Month Performance-21.39%-0.23%-3.59%1.06%1 Year Performance-1.71%25.97%31.64%26.59% Celcuity Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CELCCelcuity2.3327 of 5 stars$12.68-0.8%$29.17+130.0%-2.3%$470.81MN/A-4.8640XGNExagen4.8028 of 5 stars$4.58+9.0%$7.00+52.8%+169.2%$80.79M$52.55M-4.87220Analyst RevisionGap UpENZEnzo Biochem0.5158 of 5 stars$0.98-0.7%N/A-22.3%$51.21M$31.91M0.00520RNLXRenalytixN/A$0.21+5.7%$3.00+1,348.6%-62.3%$17.18M$2.29M-0.53100Gap UpOPGNOpGenN/A$1.99+1.5%N/A-55.8%$16.64M$3.42M0.00100News CoverageFTREFortrea3.3052 of 5 stars$19.01-0.7%$24.50+28.9%-40.7%$1.71B$3.11B0.0018,000TDOCTeladoc Health3.5544 of 5 stars$9.45+5.0%$12.08+27.8%-48.5%$1.63B$2.60B0.005,600Analyst RevisionVRDNViridian Therapeutics2.347 of 5 stars$19.82+0.2%$36.33+83.3%+22.2%$1.57B$310,000.000.0050Analyst RevisionAHCOAdaptHealth2.8439 of 5 stars$9.73+0.1%$11.67+19.9%+14.1%$1.31B$3.20B0.0010,700Analyst ForecastCDNACareDx3.9032 of 5 stars$22.31-0.3%$29.60+32.7%+131.1%$1.20B$280.32M0.00740AVAHAveanna Healthcare0.4931 of 5 stars$5.87+1.7%$4.27-27.3%+162.3%$1.13B$1.90B0.0033,500 Related Companies and Tools Related Companies Exagen Competitors Enzo Biochem Competitors Renalytix Competitors OpGen Competitors Fortrea Competitors Teladoc Health Competitors Viridian Therapeutics Competitors AdaptHealth Competitors CareDx Competitors Aveanna Healthcare Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CELC) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Celcuity Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Celcuity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
